GlucoTrack, Inc. (GCTK)
NASDAQ: GCTK · Real-Time Price · USD
0.262
-0.002 (-0.76%)
Dec 27, 2024, 4:00 PM EST - Market closed

Company Description

GlucoTrack, Inc., a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States.

It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain.

The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021.

GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.

GlucoTrack, Inc.
GlucoTrack logo
Country United States
Founded 2001
Industry Medical Instruments & Supplies
Sector Healthcare
Employees 6
CEO Paul Goode

Contact Details

Address:
301 Route 17 North, Suite 800
Rutherford, New Jersey 07070
United States
Phone 201 842 7715
Website glucotrack.com

Stock Details

Ticker Symbol GCTK
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001506983
CUSIP Number 45824Q507
ISIN Number US45824Q5071
Employer ID 98-0668934
SIC Code 3841

Key Executives

Name Position
Paul V. Goode Ph.D. Chief Executive Officer, President and Director
Mark Tapsak Ph.D. Vice President of Technology
Drinda Benjamin Vice President of Marketing
James P. Thrower Ph.D. Vice President of Engineering
Avner Gal MBA, MSc.EE Co-Founder, Chairman Emeritus, Consultant and Member of Scientific and Clinical Advisory Board
David Malka BA Co-Founder
James S. Cardwell Chief Financial Officer

Latest SEC Filings

Date Type Title
Dec 17, 2024 424B5 Filing
Dec 17, 2024 8-K Current Report
Dec 6, 2024 DEF 14A Other definitive proxy statements
Dec 3, 2024 8-K Current Report
Nov 22, 2024 PRE 14A Other preliminary proxy statements
Nov 18, 2024 8-K Current Report
Nov 14, 2024 8-K Current Report
Nov 14, 2024 10-Q Quarterly Report
Nov 14, 2024 424B4 Prospectus
Nov 13, 2024 8-K Current Report